Inger Jansen‐Olesen

4.0k total citations
100 papers, 3.2k citations indexed

About

Inger Jansen‐Olesen is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Inger Jansen‐Olesen has authored 100 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Psychiatry and Mental health, 47 papers in Cellular and Molecular Neuroscience and 35 papers in Physiology. Recurrent topics in Inger Jansen‐Olesen's work include Migraine and Headache Studies (58 papers), Neuropeptides and Animal Physiology (40 papers) and Nitric Oxide and Endothelin Effects (19 papers). Inger Jansen‐Olesen is often cited by papers focused on Migraine and Headache Studies (58 papers), Neuropeptides and Animal Physiology (40 papers) and Nitric Oxide and Endothelin Effects (19 papers). Inger Jansen‐Olesen collaborates with scholars based in Denmark, Sweden and United States. Inger Jansen‐Olesen's co-authors include Jes Olesen, Lars Edvinsson, Anders Hay‐Schmidt, Kenneth Beri Ploug, Michael Baun, Dan A. Klærke, Roshni Ramachandran, Deepak Bhatt, Alicja Mortensen and Sarah Louise Christensen and has published in prestigious journals such as PLoS ONE, Brain and Neurology.

In The Last Decade

Inger Jansen‐Olesen

98 papers receiving 3.2k citations

Peers

Countries citing papers authored by Inger Jansen‐Olesen

Since Specialization

Citations

This map shows the geographic impact of Inger Jansen‐Olesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Jansen‐Olesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Jansen‐Olesen more than expected).

Fields of papers citing papers by Inger Jansen‐Olesen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Jansen‐Olesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Jansen‐Olesen. The network helps show where Inger Jansen‐Olesen may publish in the future.

Co-authorship network of co-authors of Inger Jansen‐Olesen

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Jansen‐Olesen. A scholar is included among the top collaborators of Inger Jansen‐Olesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Jansen‐Olesen. Inger Jansen‐Olesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Topiramate Inhibits Capsaicin-Induced Mast Cell Degranulation and CGRP Release in Rat Dura Mater 2024 ·Brain Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), Juliana Ramos de Andrade, (unknown), Inger Jansen‐Olesen, Sarah Louise Christensen, Marcelo Moraes Valênça	0
2	The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development 2023 ·Frontiers in Molecular Neuroscience ·(unknown), Sarah Louise Christensen, Inger Jansen‐Olesen, Jes Olesen, Song Guo	11
3	Animal models of pain and migraine in drug discovery 2017 ·Drug Discovery Today ·Gordon Munro, Inger Jansen‐Olesen, Jes Olesen	33
4	Acetazolamide lowers intracranial pressure and modulates the cerebrospinal fluid secretion pathway in healthy rats 2017 ·Neuroscience Letters ·Maria Uldall, Hannah Botfield, Inger Jansen‐Olesen, Alexandra J. Sinclair, Rigmor Jensen	38
5	RNA Sequencing of Trigeminal Ganglia in Rattus Norvegicus after Glyceryl Trinitrate Infusion with Relevance to Migraine 2016 ·PLoS ONE ·(unknown), Lasse Maretty, Roshni Ramachandran, Jonas A. Sibbesen, (unknown), (unknown), Thomas Folkmann Hansen, Anders Krogh, Jes Olesen, Inger Jansen‐Olesen	7
6	Effect of PGD2 on middle meningeal artery and mRNA expression profile of L-PGD2 synthase and DP receptors in trigeminovascular system and other pain processing structures in rat brain 2016 ·Pharmacological Reports ·(unknown), (unknown), Inger Jansen‐Olesen, Saurabh Gupta, Majid Sheykhzade, Jes Olesen, Deepak Bhatt	8
7	mRNA distribution of CGRP and its receptor components in the trigeminovascular system and other pain related structures in rat brain, and effect of intracerebroventricular administration of CGRP on Fos expression in the TNC 2013 ·Neuroscience Letters ·Deepak Bhatt, Saurabh Gupta, Kenneth Beri Ploug, Inger Jansen‐Olesen, Jes Olesen	18
8	mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene–related peptide in the rat trigeminovascular system 2012 ·Pain ·(unknown), Kenneth Beri Ploug, Anders Hay‐Schmidt, Frank Porreca, Jes Olesen, Inger Jansen‐Olesen	66
9	Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat 2011 ·European Journal of Pharmacology ·Michael Baun, Anders Hay‐Schmidt, Lars Edvinsson, Jes Olesen, Inger Jansen‐Olesen	37
10	Evidence for CGRP re‐uptake in rat dura mater encephali 2010 ·British Journal of Pharmacology ·Saurabh Gupta, (unknown), (unknown), (unknown), Anders Hay‐Schmidt, Majid Sheykhzade, Karl Meßlinger, Jes Olesen, Inger Jansen‐Olesen	37
11	KATP channels in pig and human intracranial arteries 2008 ·European Journal of Pharmacology ·Kenneth Beri Ploug, (unknown), Lotte Strøbech, Dan A. Klærke, Anders Hay‐Schmidt, Majid Sheykhzade, Jes Olesen, Inger Jansen‐Olesen	29
12	Pharmacological and molecular comparison of KATP channels in rat basilar and middle cerebral arteries 2006 ·European Journal of Pharmacology ·Kenneth Beri Ploug, Lars Edvinsson, Jes Olesen, Inger Jansen‐Olesen	24
13	Characterization of KATP-channels in rat basilar and middle cerebral arteries: Studies of vasomotor responses and mRNA expression 2005 ·European Journal of Pharmacology ·Inger Jansen‐Olesen, (unknown), (unknown), Kenneth Beri Ploug	41
14	Peptidergic and non-peptidergic innervation and vasomotor responses of human lenticulostriate and posterior cerebral arteries 2004 ·Peptides ·Inger Jansen‐Olesen, S. Gulbenkian, Ulla Engel, (unknown), Lars Edvinsson	26
15	In-depth characterization of CGRP receptors in human intracranial arteries 2003 ·European Journal of Pharmacology ·Inger Jansen‐Olesen, (unknown), Ulla Engel, Lars Edvinsson	58
16	Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries 2001 ·European Journal of Pharmacology ·Lars Edvinsson, Anette Sams, Inger Jansen‐Olesen, János Tajti, Stefanie A. Kane, Ruth Z. Rutledge, Kenneth S. Koblan, R.G. Hill, Jenny Longmore	56
17	The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation 2001 ·European Journal of Pharmacology ·Christina Kruuse, Sergei D. Rybalkin, (unknown), Inger Jansen‐Olesen, Jes Olesen, Lars Edvinsson	44
18	Expression of calcitonin receptor-like receptor and receptor-activity-modifying proteins in human cranial arteries 1998 ·Neuroscience Letters ·Anette Sams, Inger Jansen‐Olesen	36
19	Expression of calcitonin gene-related peptide1 receptor mRNA in human trigeminal ganglia and cerebral arteries 1997 ·Neuroscience Letters ·Lars Edvinsson, (unknown), Inger Jansen‐Olesen, Rolf Uddman	52
20	Hypercapnic vasodilatation in isolated rat basilar arteries is exerted via low pH and does not involve nitric oxide synthase stimulation or cyclic GMP production 1994 ·Acta Physiologica Scandinavica ·(unknown), (unknown), (unknown), Inger Jansen‐Olesen, Olaf B. Paulson, Niels A. Lassen, Lars Edvinsson	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact